Works matching DE "TEMOZOLOMIDE"
Results: 1666
Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma.
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 3, p. 357, doi. 10.1007/s00228-016-2167-1
- By:
- Publication type:
- Article
Chemotherapy in pediatric low-grade gliomas (PLGG).
- Published in:
- Child's Nervous System, 2024, v. 40, n. 10, p. 3229, doi. 10.1007/s00381-024-06458-w
- By:
- Publication type:
- Article
Nimotuzumab-vinorelbine combination therapy versus other regimens in the treatment of pediatric diffuse intrinsic pontine glioma.
- Published in:
- Child's Nervous System, 2024, v. 40, n. 6, p. 1671, doi. 10.1007/s00381-024-06329-4
- By:
- Publication type:
- Article
A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors.
- Published in:
- Child's Nervous System, 2022, v. 38, n. 5, p. 919, doi. 10.1007/s00381-022-05479-7
- By:
- Publication type:
- Article
Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.
- Published in:
- Acta Neuropathologica, 2015, v. 129, n. 4, p. 597, doi. 10.1007/s00401-015-1403-6
- By:
- Publication type:
- Article
Mixed glioma with molecular features of composite oligodendroglioma and astrocytoma: a true 'oligoastrocytoma'?
- Published in:
- 2015
- By:
- Publication type:
- Letter
O-01 Case report: Temozolomide treatment of refractory prolactinoma.
- Published in:
- JCEM Case Reports, 2024, v. 2, p. 1, doi. 10.1210/jcemcr/luad146.047
- By:
- Publication type:
- Article
Temozolomide for Paediatric High-Grade Glioma: Time for a Rethink?
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 2, p. 4, doi. 10.17925/OHR.2023.19.2.4
- By:
- Publication type:
- Article
XPA Enhances Temozolomide Resistance of Glioblastoma Cells by Promoting Nucleotide Excision Repair.
- Published in:
- Cell Transplantation, 2022, v. 31, p. 1, doi. 10.1177/09636897221092778
- By:
- Publication type:
- Article
Commentary: Kinesin Family Member C1 Increases Resistance of Glioblastoma to Temozolomide Through Promoting DNA Damage Repair.
- Published in:
- Cell Transplantation, 2022, v. 31, p. 1, doi. 10.1177/09636897221081480
- By:
- Publication type:
- Article
Kinesin Family Member C1 Increases Temozolomide Resistance of Glioblastoma Through Promoting DNA Damage Repair.
- Published in:
- Cell Transplantation, 2021, v. 30, p. 1, doi. 10.1177/0963689721991466
- By:
- Publication type:
- Article
Effects of hispolon on glioblastoma cell growth.
- Published in:
- Environmental Toxicology, 2017, v. 32, n. 9, p. 2113, doi. 10.1002/tox.22419
- By:
- Publication type:
- Article
STING activation increases the efficiency of temozolomide in PTEN harbouring glioblastoma cells.
- Published in:
- Turkish Journal of Medical Sciences, 2024, v. 54, n. 3, p. 607, doi. 10.55730/1300-0144.5828
- By:
- Publication type:
- Article
Glioblastoma: Background, Standard Treatment Paradigms, and Supportive Care Considerations.
- Published in:
- Journal of Law, Medicine & Ethics, 2014, v. 42, n. 2, p. 171, doi. 10.1111/jlme.12133
- By:
- Publication type:
- Article
Ketogenic diets as an adjuvant therapy in glioblastoma (the KEATING trial): study protocol for a randomised pilot study.
- Published in:
- Pilot & Feasibility Studies, 2017, v. 3, p. 1, doi. 10.1186/s40814-017-0209-9
- By:
- Publication type:
- Article
Development and Application of a Slot-Blot Assay Using the Damage Sensing Protein Atl1 to Detect and Quantify O 6 -Alkylated Guanine Bases in DNA.
- Published in:
- Toxics, 2024, v. 12, n. 9, p. 649, doi. 10.3390/toxics12090649
- By:
- Publication type:
- Article
调强适形放疗联合替莫唑胺对脑胶质瘤患者生命质量及血清 VEGF、EGF 水平的影响.
- Published in:
- Progress in Modern Biomedicine, 2021, v. 21, n. 14, p. 2735, doi. 10.13241/j.cnki.pmb.2021.14.029
- By:
- Publication type:
- Article
调强适形放疗联合替莫唑胺对脑胶质瘤患者生命质量及血清VEGF、EGF水平的影响.
- Published in:
- Progress in Modern Biomedicine, 2021, n. 13, p. 2735, doi. 10.13241/j.cnki.pmb.2021.14.029
- By:
- Publication type:
- Article
MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2020, v. 24, n. 4, p. 1922
- By:
- Publication type:
- Article
CtIP contributes to non-homologous end joining formation through interacting with ligase IV and promotion of TMZ resistance in glioma cells.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2019, v. 23, n. 5, p. 2092
- By:
- Publication type:
- Article
The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study.
- Published in:
- Neuro-Oncology Practice, 2023, v. 10, n. 6, p. 555, doi. 10.1093/nop/npad037
- By:
- Publication type:
- Article
Patterns of care and survival of Chinese glioblastoma patients in the temozolomide era: a Hong Kong population-level analysis over a 14-year period.
- Published in:
- Neuro-Oncology Practice, 2023, v. 10, n. 1, p. 50, doi. 10.1093/nop/npac069
- By:
- Publication type:
- Article
Efficacy and toxicity with radiation field designs and concurrent temozolomide for CNS lymphoma.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 6, p. 536, doi. 10.1093/nop/npac052
- By:
- Publication type:
- Article
Optimal duration of adjuvant temozolomide in glioblastoma: An unsolved and unsolvable problem.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 5, p. 349, doi. 10.1093/nop/npac054
- By:
- Publication type:
- Article
Efficacy and safety of extended adjuvant temozolomide compared to standard adjuvant temozolomide in glioblastoma: Updated systematic review and meta-analysis.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 5, p. 354, doi. 10.1093/nop/npac036
- By:
- Publication type:
- Article
First-line chemotherapeutic treatment for oligodendroglioma, WHO grade 3—PCV or temozolomide?
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 3, p. 163, doi. 10.1093/nop/npac023
- By:
- Publication type:
- Article
Treatment of gliomas with temozolomide: Rather at sunrise or sunset?
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 3, p. 161, doi. 10.1093/nop/npac024
- By:
- Publication type:
- Article
Short-term outcomes associated with temozolomide or PCV chemotherapy for 1p/19q-codeleted WHO grade 3 oligodendrogliomas: A national evaluation.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 3, p. 201, doi. 10.1093/nop/npac004
- By:
- Publication type:
- Article
randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 3, p. 193, doi. 10.1093/nop/npac003
- By:
- Publication type:
- Article
Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology Practice, 2020, v. 7, n. 3, p. 268, doi. 10.1093/nop/npz057
- By:
- Publication type:
- Article
Temozolomide radiochemotherapy for high-grade glioma patients with hemodialysis: a case series of 7 patients.
- Published in:
- Neuro-Oncology Practice, 2020, v. 7, n. 1, p. 111, doi. 10.1093/nop/npz034
- By:
- Publication type:
- Article
Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network.
- Published in:
- Neuro-Oncology Practice, 2019, v. 6, n. 4, p. 264, doi. 10.1093/nop/npy051
- By:
- Publication type:
- Article
Seizure response to temozolomide chemotherapy in patients with WHO grade II oligodendroglioma: a single-institution descriptive study.
- Published in:
- Neuro-Oncology Practice, 2019, v. 6, n. 3, p. 203, doi. 10.1093/nop/npy029
- By:
- Publication type:
- Article
Neuro-Oncology Clinical Debate: PCV or temozolomide in combination with radiation for newly diagnosed high-grade oligodendroglioma.
- Published in:
- Neuro-Oncology Practice, 2019, v. 6, n. 1, p. 17, doi. 10.1093/nop/npy044
- By:
- Publication type:
- Article
Late toxicity in long-term survivors from a phase 2 study of concurrent radiation therapy, temozolomide and valproic acid for newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology Practice, 2018, v. 5, n. 4, p. 246, doi. 10.1093/nop/npy009
- By:
- Publication type:
- Article
Temozolomide therapy for aggressive functioning pituitary adenomas refractory to surgery and radiation: a case series.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Evaluation of pseudoprogression in patients with glioblastoma.
- Published in:
- Neuro-Oncology Practice, 2017, v. 4, n. 2, p. 128, doi. 10.1093/nop/npw021
- By:
- Publication type:
- Article
Impact of standard care on elderly glioblastoma patients.
- Published in:
- Neuro-Oncology Practice, 2017, v. 4, n. 1, p. 4, doi. 10.1093/nop/npw011
- By:
- Publication type:
- Article
Temozolomide treatment of pituitary carcinomas and atypical adenomas: systematic review of case reports.
- Published in:
- Neuro-Oncology Practice, 2016, v. 3, n. 3, p. 188, doi. 10.1093/nop/npv059
- By:
- Publication type:
- Article
Clinical outcome and molecular characterization of pediatric glioblastoma treated with postoperative radiotherapy with concurrent and adjuvant temozolomide: a single institutional study of 66 children.
- Published in:
- Neuro-Oncology Practice, 2016, v. 3, n. 1, p. 39, doi. 10.1093/nop/npv024
- By:
- Publication type:
- Article
Early cognitive function tests predict early progression in glioblastoma.
- Published in:
- Neuro-Oncology Practice, 2015, v. 2, n. 3, p. 137, doi. 10.1093/nop/npv007
- By:
- Publication type:
- Article
Case-Based Review: newly diagnosed glioblastoma.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience.
- Published in:
- Neuro-Oncology Practice, 2014, v. 1, n. 4, p. 172, doi. 10.1093/nop/npu028
- By:
- Publication type:
- Article
Synchronous supratentorial and infratentorial oligodendrogliomas with incongruous IDH1 mutations, a case report.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01265-9
- By:
- Publication type:
- Article
Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma.
- Published in:
- Acta Neuropathologica Communications, 2020, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40478-020-01057-7
- By:
- Publication type:
- Article
Combining dichloroacetate with temozolomide increases the antitumor efficacy of temozolomide by inhibiting HIF-1α and promoting p53 signaling pathway.
- Published in:
- Journal of Xi'an Jiaotong University (Medical Sciences), 2014, v. 35, n. 1, p. 51, doi. 10.7652/jdyxb201401011
- By:
- Publication type:
- Article
Molecular Characterization of AEBP1 at Transcriptional Level in Glioma.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5579359
- By:
- Publication type:
- Article
The Role of Hypoxia in Glioblastoma Invasion.
- Published in:
- Cells (2073-4409), 2017, v. 6, n. 4, p. 45, doi. 10.3390/cells6040045
- By:
- Publication type:
- Article
Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 10, p. 1499, doi. 10.3390/biom13101499
- By:
- Publication type:
- Article
Multi-Omics Analyses Reveal Mitochondrial Dysfunction Contributing to Temozolomide Resistance in Glioblastoma Cells.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 9, p. 1408, doi. 10.3390/biom13091408
- By:
- Publication type:
- Article